Healthcare

JNJ.N
PFE.N
MRK.N

Singapore March manufacturing output +12.1 pct y/y, exceeds expectations

SINGAPORE, April 25 - (%) March Feb Jan Dec Nov Oct m/m s/adj 6.1 6.5 -7.8 3.2 0.7 0.5 y/y 12.1 13.1 4.3 6.4 6.8 8.4 REUTERS FORECASTS m/m s/adj 1.5 y/y 6.3

Technology 1:00am EDT

Oregon's broken healthcare exchange may move to federal network

PORTLAND, April 24 - Top officials for Oregon's troubled health insurance network, dogged by technical glitches that have kept a single subscriber from enrolling online, recommended on Thursday dumping the state website in favor of a federally run healthcare exchange.

U.S./Canada daily earnings hits & misses April 24 - 1800 ET

April 24 - The following U.S.- and Canada-listed companies reported earnings on Thursday. This list shows whether they beat, met or missed Wall Street analysts' forecasts. It also shows the difference between analysts' expectations and reported results. The figures are provided by Thomson Reuters I/B/E/S. All revenue amounts are in millions. Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev 1ST SOURCE CORP

Utah sperm swap 'unacceptable' but still unexplained -university docs

April 24 - A University of Utah committee investigating reports that a Salt Lake City fertility clinic worker artificially inseminated a patient with his own sperm called the action "unacceptable" on Thursday, but said it could not determine whether the switch was intentional.

24 Apr 2014

UPDATE 1-PerkinElmer first-quarter profit tops Wall Street view

April 24 - Scientific instruments maker PerkinElmer Inc reported a higher-than-expected quarterly profit on Thursday, helped by increased demand for its medical diagnostics products and continued double-digit growth in China.

Stocks, Markets, Earnings, 24 Apr 2014
Healthcare
Johnson & Johnson $99.96 -0.26%
Pfizer Inc $30.71 -0.68%
Merck & Co Inc $57.53 +0.05%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.